Publicacions en col·laboració amb investigadors/es de Hospital Universitario Puerta de Hierro (9)

2024

  1. Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung Transplantation

    Clinical Transplantation, Vol. 38, Núm. 9

  2. Strategies for prevention and treatment of SARS-COV-2 infection in patients with chronic kidney disease: Literature review

    Nefrologia, Vol. 44, Núm. 2, pp. 150-158

  3. Strategies for prevention and treatment of SARS-CoV-2 infection in patients with chronic kidney disease: Literature review

    Nefrologia , Vol. 44, Núm. 2, pp. 150-158

2023

  1. Thrombotic microangiopathy in patients with malignant hypertension

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 5, pp. 1217-1226

2021

  1. Validation of a Histologic Scoring Index for C3 Glomerulopathy

    American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1

2019

  1. Complement activation and thrombotic microangiopathies

    Clinical Journal of the American Society of Nephrology, Vol. 14, Núm. 12, pp. 1719-1732

  2. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome

    Kidney International, Vol. 96, Núm. 4, pp. 995-1004

2017

  1. Eculizumab in secondary atypical haemolytic uraemic syndrome

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 466-474

2015

  1. Malignant hypertension: A type of IgA nephropathy manifestation with poor prognosis

    Nefrologia, Vol. 35, Núm. 1, pp. 42-49